Product Details
SARS-CoV-2 Neutralizing Antibody Rapid Test Kit
Specifications
Test Item | Neutralizing Antibody Test Kit |
Sample Volume | Whole blood 20µL, Serum/Plasma 10µL |
Package | 20 Test/Box |
Specificity | 98.00% |
Sensitivity | 97.67% |
Main Components
- Test cassettes
- Disposable pipettes
- Sterile Safety Lancets
- Sample Buffer
- Colorimetric chart
- Instruction for use
Intended Use
The kit is intended for the semi-quantitative determination of
neutraliaing antibodies to SARS-Cov-2 in human serum, plasma,
fingerstick wholeblood or venous whole bood specimens.
Product Feature
Use Step
- Place the lanceton the test site.
- Push down the lancet.
- Collect the bloodby transfer pipette.
- Add one drop of blood into the sample well.
- Add 1-2 drops (30-60µL) of sample buffer into the sample well
innediately.
- Wait 15 minutes then read the result.
Interpretation of results
- POSITIVE: The T line and C line are both displayed within the reaction
window, indicates the neutralizing antibodies to SARS-COV-2 are
detected. The result is positive.
- NEGATIVE:The C line is displayed within the reaction window only, indicates
absence of neutralizing antibody to SARS-COV-2.The result is
negative..
- INVALID:1. If the control (C) line is not displayed in 15 min, regardless
of whether T line is present, the test result is invalid. It is
recommended that the specimen should be re-tested.
2.The test result is invalid after 20 min.
Company Profile
Labnovation Technologies, Inc. is an original manufacturer
established in Shenzhen, China since 2001. We are dedicated in
developing and manufacturing IVD instruments and reagents including
HbA1c analyzer and reagents, rapid test reader & reagents,
hematology reagents, clinical chemistry reagents, electrolyte
reagents, wash solution and urine test reagents.
Labnovation products are developed in house, tested extensively in
clinics and passed strict quality controls. All of our products are
CE marked and approved by SFDA. In the past 15 years, our products
have been exported to 110 different countries and used in 8000
hospitals worldwide. We provide both ready-to-use final products
and bulk OEM reagents, including ready-to-use reagents,
concentrated, and powder.
With an investment of 10% of our annual sales into R&D, we
release new products every years. We win more and more domestic and international cooperation by
company reputation and products quality while we actively take part
in fairs like MEDICA,AACC, ARBA HEALTH and so on through which we
are well-known by the companies in this field.